Shin Ryoku Trust is an Australian-based discretionary investment trust that focuses on entrepreneurship and making a positive impact on the world. With an emphasis on far-sighted actions, Shin Ryoku Trust aims to create a better future through its investments. The trust has recently invested in several ventures, including Breakaway Labs, a company dedicated to health and mobile technologies.

Another investment is in Human Longevity, Inc., which specializes in health-related advancements. Verbling, a language learning start-up, is also among the trust's portfolio. Additionally, Shin Ryoku Trust has invested in Spire, a company in the health, mobile, and start-up sectors.

In recent news, Shin Ryoku Trust proudly led a successful seed fundraising round of S$140,000 for Healint Pte Ltd, a Singapore-based company. Healint is set to graduate from the prestigious JFDI accelerator program in Asia, and the funding round included investors from Singapore, France, Australia, and Japan. Shin Ryoku Trust remains committed to nurturing and supporting innovative ventures that have the potential to make a significant difference in various industries